NFKB1 and diffuse large B-cell lymphoma: The ABC subtype of DLBCL typically exhibits constitutive activation of the nuclear factor-kappaB (NF-κB) pathway [4, 5] and patients have inferior clinical outcomes compared with patients with GCB-DLBCL [6, 7].